{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:35:27Z","timestamp":1770824127185,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hospital admissions are a missed opportunity to engage people living with hepatitis C virus (HCV) into care. This study aimed to describe the proportion of hospital inpatients and emergency department (ED) patients identified with hepatitis C who were subsequently linked to care and treatment at a metropolitan health service in Melbourne, Australia. Data were collected retrospectively from hospital databases (admissions, notifiable diseases, and pharmacy) for all adults admitted or attending the ED with separation coding indicating hepatitis C infection from March 2016 to March 2019. There were 2149 patients with at least one separation with hepatitis C coding. 15.4% (331\/2149) had a documented antibody test, 4.6% (99\/2149) had a documented RNA test, and 8.3% (179\/2149) had a DAA prescription dispensed by hospital pharmacy. Antibody positivity was 95.2% (315\/331) and RNA (when completed) was detected in 37.4% (37\/99). Hepatitis specialist units had the highest rate of hepatitis C coded separations and RNA testing (39\/88; 44.3%), mental health had the highest rate of antibody testing (70\/276; 25.4%). Emergency had the lowest rate of antibody testing (101\/1075; 13.7%) and the third highest rate of RNA testing (32\/94; 34.1%), but the highest rate of RNA detected (15\/32; 46.9%). This study highlights key steps to improve the care cascade. Simplified diagnostic pathways, expansion of hepatitis C care services, and clear in-hospital pathways to link patients to care would be beneficial in this setting. To scale up hepatitis C testing and treatment as part of national elimination strategies, hospital systems need to target interventions to their local data.<\/jats:p>","DOI":"10.3390\/v15040913","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T03:32:59Z","timestamp":1680492779000},"page":"913","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Leave No-One Behind: A Retrospective Study of Hepatitis C Testing and Linkage to Care for Hospital Inpatients"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3516-887X","authenticated-orcid":false,"given":"Christine","family":"Roder","sequence":"first","affiliation":[{"name":"Disease Elimination Program, Burnet Institute, Melbourne 3004, Australia"},{"name":"Centre for Innovation in Infectious Disease and Immunology Research (CIIDIR), Deakin University, Geelong 3220, Australia"},{"name":"Barwon South West Public Health Unit, Barwon Health, Geelong 3220, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Cosgrave","sequence":"additional","affiliation":[{"name":"Barwon South West Public Health Unit, Barwon Health, Geelong 3220, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Mackie","sequence":"additional","affiliation":[{"name":"Barwon South West Public Health Unit, Barwon Health, Geelong 3220, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart K.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret E.","family":"Hellard","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute, Melbourne 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Wade","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute, Melbourne 3004, Australia"},{"name":"Centre for Innovation in Infectious Disease and Immunology Research (CIIDIR), Deakin University, Geelong 3220, Australia"},{"name":"Barwon South West Public Health Unit, Barwon Health, Geelong 3220, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Doyle","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute, Melbourne 3004, Australia"},{"name":"Department of Infectious Disease, Alfred Health and Monash University, Melbourne 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2023, March 21). Global Hepatitis Report 2017, Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241565455."},{"key":"ref_2","unstructured":"World Health Organization (2023, March 21). Accelerating Access to Hepatitis C Diagnostics and Treatment: Overcoming Barriers in Low- and Middle-Income Countries, Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240019003."},{"key":"ref_3","unstructured":"World Health Organization (2023, February 02). Global Health Sector Strategy on Viral Hepatitis 2016\u20132021. Towards Ending Viral Hepatitis, Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/246177."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40258-018-0392-8","article-title":"Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia","volume":"16","author":"Yee","year":"2018","journal-title":"Appl. Health Econ. Health Policy"},{"key":"ref_5","unstructured":"MacLachlan, J.H., Stewart, S., and Cowie, B.C. (2020). Viral Hepatitis Mapping Project: National Report 2020, Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine (ASHM). Available online: https:\/\/www.ashm.org.au\/programs\/Viral-Hepatitis-Mapping-Project\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S2055-6640(20)30253-3","article-title":"Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: A geospatial analysis of a year of unrestricted treatment access","volume":"4","author":"Scott","year":"2018","journal-title":"J. Virus Erad."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/cid\/ciab526","article-title":"Opportunities to enhance linkage to hepatitis C care among hospitalized people with recent drug dependence in New South Wales, Australia: A population-based linkage study","volume":"73","author":"Valerio","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/jvh.12910","article-title":"Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C","volume":"25","author":"Wade","year":"2018","journal-title":"J. Viral Hepat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jvh.13622","article-title":"Psychiatrists can treat hepatitis C","volume":"28","author":"Roder","year":"2021","journal-title":"J. Viral Hepat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.15107","article-title":"A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia","volume":"42","author":"Harney","year":"2022","journal-title":"Liver Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/jvh.13487","article-title":"Hepatitis C treatment in a co-located mental health and alcohol and drug service using a nurse-led model of care","volume":"28","author":"Harney","year":"2021","journal-title":"J. Viral Hepat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/apt.15210","article-title":"Treatment access is only the first step to hepatitis C elimination: Experience of universal anti-viral treatment access in Australia","volume":"49","author":"Doyle","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_13","unstructured":"Burnet Institute, and Kirby Institute (2022). Australia\u2019s Progress towards Hepatitis C Elimination: Annual Report 2022, Burnet Institute."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.07.006","article-title":"Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade","volume":"47","author":"Scott","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rosato, V., Kondili, L.A., Nevola, R., Perillo, P., Mastrocinque, D., Aghemo, A., and Claar, E. (2022). Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions. Viruses, 14.","DOI":"10.3390\/v14051096"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s10620-021-06941-3","article-title":"Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C Treatment","volume":"67","author":"Le","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100279","DOI":"10.1016\/j.jhepr.2021.100279","article-title":"Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy","volume":"3","author":"Girardin","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_18","unstructured":"(2023, February 15). Alfred Health Annual Report 2019\u20132020. Available online: https:\/\/www.alfredhealth.org.au\/about\/corporate-publications?category=66|88."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"WHO (2022, January 17). ICD\u201310\/2019 Revision, Available online: https:\/\/icd.who.int\/browse10\/2019\/en.","DOI":"10.1542\/pcco_book214_document006"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/cid\/ciz546","article-title":"Outcomes of treatment for hepatitis C in primary care, compared to hospital-based care: A randomized, controlled trial in people who inject drugs","volume":"70","author":"Wade","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugpo.2019.06.021","article-title":"Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department","volume":"72","author":"Hutton","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.drugpo.2018.11.003","article-title":"Opportunistic assessment and treatment of people with hepatitis C virus infection admitted to hospital for other reasons: A prospective cohort study","volume":"65","author":"Chiong","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1753-6405.13109","article-title":"Pregnancy\u2014A key moment for engaging women with hepatitis B in care","volume":"45","author":"Roder","year":"2021","journal-title":"Aust. New Zealand J. Public Health"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Podubinski, T., Townsin, L., Thompson, S.C., Tynan, A., and Argus, G. (2021). Experience of healthcare access in Australia during the first year of the COVID-19 pandemic. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182010687"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/4\/913\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:08:02Z","timestamp":1760123282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/4\/913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["v15040913"],"URL":"https:\/\/doi.org\/10.3390\/v15040913","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}